Get in touch
Close

Contacts

Sarvodaya Hospital,
Sector 8,
Faridabad, Haryana, India

+ (91) 9355258181

info@theranos.care

FAPI PET Scan

Summary in a Minute

The FAPI PET scan targets fibroblast activation protein (FAP), which is highly expressed in many cancers, particularly in cancer-associated fibroblasts. By using a radiolabeled FAPI tracer, this imaging technique allows for precise tumor detection and early cancer diagnosis. It provides high sensitivity for identifying tumors and metastases, even in their early stages. FAPI PET Scan is particularly useful for detecting cancers like pancreatic cancer, sarcomas, and lung cancer, and plays a crucial role in monitoring disease progression and guiding treatment strategies for personalized care.

Overview

The FAPI PET scan (Fibroblast Activation Protein Inhibitor Positron Emission Tomography) is an advanced imaging technique designed to detect a wide range of cancers. It targets fibroblast activation protein (FAP), which is overexpressed in many tumors, particularly in cancer-associated fibroblasts within the tumor microenvironment. The radiolabeled FAPI tracer binds to these proteins, allowing for precise imaging of tumors and metastases. FAPI PET has shown promise in detecting various cancers, including sarcomas, pancreatic cancer, and lung cancer. It provides high sensitivity for early diagnosis and is useful for treatment planning and monitoring.

Procedure

1. Patient preparation: fasting, hydration
2. 68Ga-FAPI injection (typically 2-5 mCi)
3. Uptake period (30-60 minutes)
4. PET scan (10-30 minutes)

Indications

1. Cancer diagnosis and staging
2. Tumor characterization
3. Treatment response assessment
4. Cancer of unknown primary (CUP)

Principle

1. FAPI binds to Fibroblast Activation Protein (FAP) on CAFs.
2. 68Ga labels FAPI.
3. PET scanner detects positrons emitted by 68Ga.

Benefits

1. High sensitivity and specificity for cancer detection: FAPI PET precisely detects tumors by targeting fibroblast activation protein, offering accurate cancer imaging with minimal false positives.
2. Whole-body imaging: Provides comprehensive, 3D scans of the entire body, detecting primary tumors and metastases in various organs and tissues.
3. Improved detection of small lesions: FAPI PET can identify small or early-stage lesions that may be missed by other imaging methods, enabling earlier treatment.
4. Potential for theranostics: FAPI PET offers potential for combined therapy and diagnostics (theranostics), targeting cancer cells for both imaging and targeted treatment options.

Limitations

1. False positives (e.g., inflammation, physiological uptake)
2. False negatives (e.g., low FAP expression)
3. Radiation exposure

Comparison with other imaging modalities

1. FDG PET Scan: lower specificity for cancer detection
2. PSMA PET Scan: lower sensitivity for non-prostate cancer
3. MRI: lower sensitivity for small lesions
4. CT: lower sensitivity for soft tissue lesions

Emerging Trends

1. Theranostics: 177Lu-FAPI therapy
2. FAPI PET-guided biopsy
3. Artificial intelligence-based image analysis
4. Combination with other tracers (e.g., PSMA, DOTATATE)

FAQs about FAPI PET Scan

It can detect a range of cancers, including pancreatic, sarcomas, and lung cancer.

The scan typically takes 30-60 minutes, plus time for tracer administration.

Yes, it’s a safe procedure with minimal radiation exposure and rare side effects.

Generally, no special preparation is needed, but fasting may be recommended.

Contact Information

Contact for appointments for Scans and Therapies.

Phone

+91-9650057298
+91-9355258181

Email
info@theranos.care
Address
Sarvodaya Hospital, 
Sector 8, Faridabad, Haryana, India

Get in Touch

Define a Clinic or Appointment related query and send to us.